COVID-19, heavy drinking and alcohol use disorders: a national study of Veterans Administration patients
COVID-19、酗酒和酒精使用障碍:一项针对退伍军人管理局患者的全国研究
基本信息
- 批准号:10596115
- 负责人:
- 金额:$ 18.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcute Respiratory Distress SyndromeAddressAffectAgeAlcohol consumptionAlcoholsBackBehavioralBig DataBiologicalBlack PopulationsBlack raceCOVID-19COVID-19 prognosisCOVID-19 riskCOVID-19 severityCOVID-19 susceptibilityCOVID-19 vaccinationCaringCause of DeathCessation of lifeCharacteristicsChronicComputerized Medical RecordCountyDataDatabasesDiabetes MellitusDiagnosisDiagnosticDisastersDiseaseEthnic OriginEventExploratory/Developmental GrantFundingFutureGeneral PopulationHealthHealth behaviorHeavy DrinkingHispanicHispanic PopulationsHospitalizationHypertensionICD-10-CMImmune responseImmune systemImpairmentIndividualInfectionIntensive CareKnowledgeLinkLogistic RegressionsMedicalMedicareMinorityMisinformationModelingNational Institute on Alcohol Abuse and AlcoholismObesityOutcomePatientsPersonsPneumoniaPoliciesPovertyPrevalencePreventiveProcessPrognosisProviderRaceResearch InfrastructureRetrospective cohortRiskSARS-CoV-2 exposureSARS-CoV-2 infectionSARS-CoV-2 negativeScientistServicesSocial EnvironmentStatistical Data InterpretationStressTestingTimeUnited States Department of Veterans AffairsVaccinatedVaccinationVaccinesVeteransVirus DiseasesVital Statusalcohol effectalcohol screeningalcohol use disordercopingcostdata repositorydata resourcedata sharingdata sharing networksdemographicsdesigndrinkingelectronic medical record systemhousing instabilityhuman old age (65+)indexinginfection riskinterestmalemenmortalitynovel coronaviruspandemic diseaseresidenceservice providerssexsociodemographicsvaccine distributionvaccine hesitancy
项目摘要
Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 is a global pandemic. While most COVID-19
cases are mild or moderate, severe cases (~15%) require hospitalization, critical cases (~5%) require intensive
care, and many deaths occur. Males, Blacks and Hispanics are at greater risk for COVID-19 infection, and poor
prognosis is predicted by older age, race/ethnicity, and prior underlying medical conditions. A potentially critical
factor not yet studied is heavy alcohol use or alcohol use disorder (AU/AUD). AU/AUD could increase the risk
for COVID-19 infection and poor prognosis through poor health behaviors, by direct effects of alcohol on the
immune system, or by indirect effects due to the greater prevalence of underlying medical conditions that predict
poor COVID-19 prognosis. Little is known about the relationship of AU/AUD to the likelihood of COVID-19
vaccination, infection, or poor prognosis, and if these relationships are modified by medical conditions (e.g.,
hypertension, obesity, diabetes), spatially-defined socioenvironmental or exposure variables (e.g., county
poverty or COVID-19 rates) or demographic characteristics (sex, age, race/ethnicity, poverty). To study this,
large databases are needed that include AU/AUD, demographic characteristics, spatial identifiers, diagnostic,
treatment and mortality information. Responding to PA-20-195 (and addressing issues in NOT-AA-20-011), we
will utilize the Veterans Administration (VA) Electronic Medical Record (EMR) system for this purpose. The VA
treats 6.3 million veterans a year. VA patients have high rates of COVID-19 vulnerability factors, e.g., male, older
age, chronic medical conditions. A VA Shared Data Resource identifies COVID-19 cases (now N=186,174, with
9,299 deaths). The many VA patients with ICD-10-CM AUD or positive alcohol (AUDIT-C) screens provide
extensive data on whether the likelihood of COVID-19 outcomes differ by AU/AUD status. Leveraging a research
infrastructure established in an existing project, we propose a 2-year study to comprehensively address the
relationship of AU/AUD to COVID-19 vaccination, infection and prognosis, and how these relationships are
affected by demographic, medical, spatial exposure characteristics. Aim1: Determine the relationship of AU/AUD
to COVID-19 vaccination, infection, and in those infected, poor prognosis (e.g., hospitalization, ICU treatment,
death). Aim 2: Determine if associations of AU/AUD with COVID-19 outcomes vary over time, medical conditions
(e.g., hypertension, obesity, diabetes), spatial exposures or demographic characteristics. In Year 01, we will
analyze EMR diagnostic, treatment, and vital status death data, using a 12-month lookback period to determine
AU/AUD and medical conditions that preceded COVID-19 outcome variables. In Year 02, we will incorporate
National Death Index data to examine causes of death, and expand information on veterans ≥age 65 with
Medicare data. Logistic regression will evaluate differences in COVID-19 outcomes by AU/AUD status. Among
those with COVID-19, survival models will determine if time to poor prognosis events differs by AU/AUD. Results
will fill major gaps in knowledge about the risks for and prognosis of COVID-19 among those with AU/AUD.
由 SARS-CoV-2 引起的 2019 年冠状病毒病 (COVID-19) 是一种全球性流行病,而大多数 COVID-19 都是如此。
病例为轻度或中度,重症病例(~15%)需要住院治疗,重症病例(~5%)需要重症监护
男性、黑人和西班牙裔以及穷人感染 COVID-19 的风险更大。
预后是根据年龄、种族/民族和先前的潜在健康状况来预测的。
尚未研究的因素是大量饮酒或酒精使用障碍(AU/AUD)可能会增加风险。
对于因不良健康行为而导致的 COVID-19 感染和不良预后、酒精对身体的直接影响
免疫系统,或由于预测潜在医疗状况的普遍存在而产生的间接影响
对于 AU/AUD 与 COVID-19 可能性的关系知之甚少。
疫苗接种、感染或预后不良,以及这些关系是否因医疗状况而改变(例如,
高血压、肥胖、糖尿病)、空间定义的社会环境或暴露变量(例如县
贫困率或 COVID-19 率)或人口特征(性别、年龄、种族/民族、贫困)。
需要大型数据库,包括 AU/AUD、人口特征、空间标识符、诊断、
响应 PA-20-195(并解决 NOT-AA-20-011 中的问题),我们
为此目的,将利用退伍军人管理局 (VA) 电子病历 (EMR) 系统。
每年治疗 630 万名退伍军人,其中有较高比例的 COVID-19 易感因素,例如男性、老年人。
VA 共享数据资源确定了 COVID-19 病例(目前 N=186,174 例,其中
9,299 例死亡)许多 VA 患者的 ICD-10-CM AUD 或酒精 (AUDIT-C) 筛查呈阳性。
利用研究,了解有关 COVID-19 结果的可能性是否因 AU/AUD 状态而异的大量数据。
针对现有项目中建立的基础设施,我们建议进行为期 2 年的研究,以全面解决
AU/AUD 与 COVID-19 疫苗接种、感染和预后的关系,以及这些关系如何
受人口、医疗、空间暴露特征的影响 目标 1:确定 AU/AUD 的关系。
COVID-19 疫苗接种、感染以及感染者的预后不良(例如住院、ICU 治疗、
目标 2:确定 AU/AUD 与 COVID-19 结果的关联是否随时间、医疗条件而变化
(例如高血压、肥胖、糖尿病)、空间暴露或人口特征。在第一年,我们将。
使用 12 个月的回顾期分析 EMR 诊断、治疗和生命状态死亡数据,以确定
在第 02 年,我们将纳入 AU/AUD 和 COVID-19 结果变量之前的医疗状况。
国家死亡指数数据用于检查死亡原因,并扩展 65 岁以上退伍军人的信息
医疗保险数据。Logistic 回归将按 AU/AUD 状态评估 COVID-19 结果的差异。
对于患有 COVID-19 的患者,生存模型将确定不良预后事件发生的时间是否因 AU/AUD 结果而异。
将填补 AU/AUD 患者对 COVID-19 风险和预后的主要知识空白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORAH S HASIN其他文献
DEBORAH S HASIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORAH S HASIN', 18)}}的其他基金
COVID-19, heavy drinking and alcohol use disorders: a national study of Veterans Administration patients
COVID-19、酗酒和酒精使用障碍:一项针对退伍军人管理局患者的全国研究
- 批准号:
10371482 - 财政年份:2022
- 资助金额:
$ 18.72万 - 项目类别:
Scientific Conferences for The College on Problems of Drug Dependence (CPDD)
药物依赖问题学院科学会议(CPDD)
- 批准号:
10610865 - 财政年份:2021
- 资助金额:
$ 18.72万 - 项目类别:
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024
医用和娱乐大麻法对大麻、阿片类药物和精神药物的影响:2000 年至 2024 年退伍军人事务部患者的全国研究
- 批准号:
10393578 - 财政年份:2019
- 资助金额:
$ 18.72万 - 项目类别:
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024
医用和娱乐大麻法对大麻、阿片类药物和精神药物的影响:2000 年至 2024 年退伍军人事务部患者的全国研究
- 批准号:
10612385 - 财政年份:2019
- 资助金额:
$ 18.72万 - 项目类别:
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints - Administrative Supplement
饮酒水平(酗酒、饮酒量)和酒精后果:使用国家数据确定临床试验终点 - 行政补充
- 批准号:
10228425 - 财政年份:2016
- 资助金额:
$ 18.72万 - 项目类别:
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints
饮酒水平(酗酒、饮酒量)和酒精后果:使用国家数据确定临床试验终点
- 批准号:
9440313 - 财政年份:2016
- 资助金额:
$ 18.72万 - 项目类别:
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints
饮酒水平(酗酒、饮酒量)和酒精后果:使用国家数据确定临床试验终点
- 批准号:
9883624 - 财政年份:2016
- 资助金额:
$ 18.72万 - 项目类别:
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependence
HealthCall:加强对艾滋病毒初级保健酒精依赖的短期干预
- 批准号:
9317400 - 财政年份:2014
- 资助金额:
$ 18.72万 - 项目类别:
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependence
HealthCall:加强对艾滋病毒初级保健酒精依赖的短期干预
- 批准号:
8932642 - 财政年份:2014
- 资助金额:
$ 18.72万 - 项目类别:
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependence
HealthCall:加强对艾滋病毒初级保健酒精依赖的短期干预
- 批准号:
8731034 - 财政年份:2014
- 资助金额:
$ 18.72万 - 项目类别:
相似国自然基金
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
锌离子转运蛋白SLC39A1在急性呼吸窘迫综合征中的作用和机制
- 批准号:32371177
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
β-catenin诱导调节性T细胞代谢重编程及亚型转化在急性呼吸窘迫综合征的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
特络细胞源性外泌体经JAK/STAT-miRNA-E2F轴修复肺血管改善急性呼吸窘迫综合征的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
- 批准号:
10639707 - 财政年份:2023
- 资助金额:
$ 18.72万 - 项目类别:
Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections
用于治疗 COVID-19 和其他人类冠状病毒感染的口服生物可利用抑制剂的优化
- 批准号:
10698831 - 财政年份:2023
- 资助金额:
$ 18.72万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 18.72万 - 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
- 批准号:
10748433 - 财政年份:2023
- 资助金额:
$ 18.72万 - 项目类别: